Close

Wells Fargo Upgrades AmSurg (AMSG) to Outperform

Go back to Wells Fargo Upgrades AmSurg (AMSG) to Outperform

AmSurg (AMSG) Reports In-Line Q3 EPS, FY Rev. Guidance Tops Consensus

November 1, 2016 4:28 PM EDT

AmSurg (NASDAQ: AMSG) reported Q3 EPS of $1.13, in-line with the analyst estimate of $1.13. Revenue for the quarter came in at $822.2 billion versus the consensus estimate of $770.29 million.

GUIDANCE:

AmSurg sees Q4 2016 EPS of $1.23, versus the consensus of $1.28.

AmSurg... More